HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuo Iida Selected Research

Body Weight (Weight, Body)

10/2021d-Allulose Ameliorates Skeletal Muscle Insulin Resistance in High-Fat Diet-Fed Rats.
2/2018Secretion of GLP-1 but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats.
11/2017d-Allulose enhances postprandial fat oxidation in healthy humans.
1/2017Comparison of Anti-Obesity Effect between Two Types of Syrup Containing Rare Sugars in Wistar Rats.
1/2015[Safety Evaluation of Rare Sugar Syrup: Single-dose Oral Toxicity in Rats, Reverse Mutation Assay, Chromosome Aberration Assay, and Acute Non-Effect Level for Diarrhea of a Single Dose in Humans].
6/2013Reduction of abdominal fat accumulation in rats by 8-week ingestion of a newly developed sweetener made from high fructose corn syrup.
1/2013Inhibition by dietary D-psicose of body fat accumulation in adult rats fed a high-sucrose diet.
2/2010Failure of d-psicose absorbed in the small intestine to metabolize into energy and its low large intestinal fermentability in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuo Iida Research Topics

Disease

8Obesity
09/2022 - 01/2013
8Body Weight (Weight, Body)
10/2021 - 02/2010
4Insulin Resistance
01/2022 - 04/2017
1isovaleric Acidemia
05/2022
1Fatigue
01/2022
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Inflammation (Inflammations)
01/2022
1Diabetes Mellitus
01/2021
1Atherosclerosis
04/2020
1Glucose Intolerance
02/2018
1Weight Gain
01/2017
1Diarrhea
01/2015
1Chromosome Aberrations (Chromosome Abnormalities)
01/2015
1Metrorrhagia (Spotting)
12/2006

Drug/Important Bio-Agent (IBA)

14psicose (D-psicose)IBA
09/2022 - 02/2010
5SugarsIBA
05/2021 - 01/2015
4Sucrose (Saccharose)IBA
09/2021 - 01/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2010
3Sweetening Agents (Sweeteners)IBA
04/2020 - 01/2017
2FructoseIBA
05/2021 - 11/2017
2High Fructose Corn SyrupIBA
04/2017 - 06/2013
1Indicators and Reagents (Reagents)IBA
05/2022
1pivaloylcarnitineIBA
05/2022
13-methylbutyrylcarnitineIBA
05/2022
1Insulin (Novolin)FDA Link
01/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1HDL CholesterolIBA
04/2020
1Glucagon-Like Peptide 1 (GLP 1)IBA
02/2018
1CarbohydratesIBA
11/2017
1GlucokinaseIBA
04/2017
1MonosaccharidesIBA
01/2017
1EnzymesIBA
03/2014
1Starch (Cornstarch)IBA
06/2013
1Peptides (Polypeptides)IBA
12/2006